740P Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC): Exploratory biomarker analyses of the phase IIIb OPINION study
暂无分享,去创建一个
A. Barnicle | N. Colombo | K. Lindemann | A. Poveda | E. Škof | J. Bennett | R. Davidson | C. Blakeley | A. González-Martín